Home Newsletters Pancreatic Cell News Combinational Blockade of MET and PD-L1 Improves Pancreatic Cancer Immunotherapeutic Efficacy

Combinational Blockade of MET and PD-L1 Improves Pancreatic Cancer Immunotherapeutic Efficacy

0
Kaplan–Meier plotter was used to analyze the prognostic significance of each of the all-known receptor tyrosine kinases to date in immune “hot” and “cold” pancreatic cancers.
[Journal of Experimental & Clinical Cancer Research]

Sorry, but the selected Zotpress account can't be found.

Full Article
Exit mobile version